Invitrogen™ Human TMEM70 Synthetic Peptide

Ref.: BL-RE-177042Manufacturer ref.: PEP-1029 50 μg
€149.00 excl. VAT

TMEM70 Synthetic Peptide, PEP-1029, from Invitrogen.

Gene ID (Enter)
54968
Species
Human
Purification method
Purified
Accession number
Q9BUB7
Common name
Human TMEM70
Brand
Invitrogen

TMEM70 Synthetic Peptide, PEP-1029, from Invitrogen.

TMEM70 Synthetic Peptide, PEP-1029, from Invitrogen.

TMEM70 is a recently identified mitochondrial protein that is thought to play a role in the biogenesis of the ATP synthase in higher eukaryotes. Mutations in this gene result in early neonatal onset of hypotonia, hypertrophic cardiomyopathy, lactic acidos and 3-methylglutaconic aciduria (3-MGC-uria), and usually cause death within the first six weeks of life, although some patients survive much longer. Little is known of the role of TMEM70, but it is conserved across multicellular eukaryotic organisms. It contains a conserved DUF1301 domain and two putative transmembrane regions.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15265029
Specifications
Gene ID (Enter)54968
SpeciesHuman
Purification methodPurified
Accession numberQ9BUB7
Common nameHuman TMEM70
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)TMEM70
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1029
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.